Hjem › Autoimmune sygdomme › Florida › Tampa
Autoimmune sygdomme kliniske forsøg i Tampa, FL
4 studier for Autoimmune sygdomme søger deltagere på steder i og omkring Tampa (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RekruttererFase 3
- Clinical Research of West Florida Inc, Tampa
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
RekruttererFase 2
- GCP Clinical Research, Tampa
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RekruttererFase 3
- Site Number - 1007, Tampa
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RekruttererFase 1
- University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa
Autoimmune sygdomme forsøg i andre byer
- Houston, TX21 studier
- Washington, DC19 studier
- New York City, NY19 studier
- Philadelphia, PA16 studier
- Durham, NC15 studier
- Boston, MA13 studier
- Los Angeles, CA12 studier
- Chicago, IL12 studier
- Dallas, TX9 studier
- Cleveland, OH8 studier
- Milwaukee, WI8 studier
- Atlanta, GA8 studier
Andre studier i Tampa
- Ikke-småcellet lungecancer51 studier
- Brystkræft43 studier
- Kræft (alle typer)39 studier
- Colorektal kræft33 studier
- Metastatisk cancer29 studier
- Lungecancer29 studier
- Akut myeloid leukæmi29 studier
- Bugspytkirtelkræft26 studier
- Ægstockræft21 studier
- Myelodysplastiske syndromer19 studier
- Melanom19 studier
- Hjertesvigt18 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.